CoQuit Study for Smoking Cessation

A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation

This study investigates the feasibility of a cognitive dissonance-based mobile app for smoking cessation (CDI). Cognitive dissonance refers to the conflict between beliefs and behaviors; interventions are designed to promote this conflict to motivate people to change their behavior. Recent research has demonstrated the efficacy and potential of using cognitive dissonance interventions for a wide range of health and behavioral problems including smoking cessation. This study will develop an initial version of the CDI mobile app and evaluate the app in an evaluation study with 60 adult smokers.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A group of 60 adult smokers will use and evaluate the initial version of the CoQuit app. All participants will be recruited through social media; they will be screened and consented online. After enrolling, participants will receive a link to the baseline survey which asks about past and current tobacco use, nicotine dependence, motivation to quit, cognitive dissonance and demographic information. All participants will then be assigned to an online support group of 5 or 6 people. The group will receive simultaneous invites to the app so they can move through the 25 day program together. The app contains short videos of a CoQuit facilitator who presents instructions for specific tasks, such as writing a brief letter to a friend or family member explaining the decision to stop smoking. Participants will make videos of themselves related to these activities and post the videos within the app where they can be viewed by other members of the group. All participants will complete a six weeks post baseline online assessment asking about past and current tobacco use, quit attempts, and thoughts about navigation, ease of program use, and possible improvements to the app.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Eugene, Oregon, United States, 97403
        • ORBIS/Oregon Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18 or older
  • Self-reported daily smoking
  • Having a valid home mailing address
  • English speaking
  • Access to a smartphone with video capability and internet
  • Not currently participating in any tobacco cessation programs
  • Expressed desire to quit smoking

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
All participants will use the CoQuit App for Smoking Cessation
The CoQuit App is a cognitive dissonance based app for smoking cessation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tobacco Abstinence
Time Frame: Six weeks post baseline
Self report of quitting tobacco use
Six weeks post baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attempts to Quit Smoking
Time Frame: Six weeks post baseline
Self report of successful attempts to not smoke for 24 hours or more
Six weeks post baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dana Smith, PhD, Influents Innovations/Oregon Research Institute
  • Principal Investigator: Herb Severson, PhD, Influents Innovations/Oregon Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

September 29, 2021

Study Completion (Actual)

September 29, 2021

Study Registration Dates

First Submitted

May 14, 2021

First Submitted That Met QC Criteria

May 14, 2021

First Posted (Actual)

May 19, 2021

Study Record Updates

Last Update Posted (Actual)

March 26, 2024

Last Update Submitted That Met QC Criteria

March 25, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • DP006495-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on CoQuit App

3
Subscribe